Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of Cardiovascular Disease Risk Factors Between 2 Subclinical Atherosclerosis Measures in Healthy Postmenopausal Women: Carotid Artery Wall Thickness and Echogenicity: Carotid Artery Wall Thickness and Echogenicity.
Karim R, Xu W, Kono N, Li Y, Yan M, Stanczyk FZ, Hodis HN, Mack WJ. Karim R, et al. Among authors: yan m. J Ultrasound Med. 2023 Jan;42(1):35-44. doi: 10.1002/jum.15985. Epub 2022 Apr 7. J Ultrasound Med. 2023. PMID: 35388917 Free PMC article. Clinical Trial.
Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women: a randomized controlled trial.
Hodis HN, Mack WJ, Kono N, Azen SP, Shoupe D, Hwang-Levine J, Petitti D, Whitfield-Maxwell L, Yan M, Franke AA, Selzer RH; Women's Isoflavone Soy Health Research Group. Hodis HN, et al. Among authors: yan m. Stroke. 2011 Nov;42(11):3168-75. doi: 10.1161/STROKEAHA.111.620831. Epub 2011 Sep 8. Stroke. 2011. PMID: 21903957 Free PMC article. Clinical Trial.
Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial.
Basaria S, Harman SM, Travison TG, Hodis H, Tsitouras P, Budoff M, Pencina KM, Vita J, Dzekov C, Mazer NA, Coviello AD, Knapp PE, Hally K, Pinjic E, Yan M, Storer TW, Bhasin S. Basaria S, et al. Among authors: yan m. JAMA. 2015 Aug 11;314(6):570-81. doi: 10.1001/jama.2015.8881. JAMA. 2015. PMID: 26262795 Clinical Trial.
Nattokinase atherothrombotic prevention study: A randomized controlled trial.
Hodis HN, Mack WJ, Meiselman HJ, Kalra V, Liebman H, Hwang-Levine J, Dustin L, Kono N, Mert M, Wenby RB, Huesca E, Rochanda L, Li Y, Yan M, St John JA, Whitfield L. Hodis HN, et al. Among authors: yan m. Clin Hemorheol Microcirc. 2021;78(4):339-353. doi: 10.3233/CH-211147. Clin Hemorheol Microcirc. 2021. PMID: 33843667 Clinical Trial.
7,184 results